Parallel Advisors’s PetMed Express PETS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-34
Closed -$138 3454
2024
Q2
$138 Hold
34
﹤0.01% 3232
2024
Q1
$163 Sell
34
-223
-87% -$1.3K ﹤0.01% 3173
2023
Q4
$1.94K Hold
257
﹤0.01% 2816
2023
Q3
$2.63K Sell
257
-1,462
-85% -$18K ﹤0.01% 2731
2023
Q2
$23.7K Buy
1,719
+1,076
+167% +$16.2K ﹤0.01% 1770
2023
Q1
$10.4K Buy
643
+86
+15% +$1.62K ﹤0.01% 2110
2022
Q4
$9.87K Buy
557
+239
+75% +$4.75K ﹤0.01% 2030
2022
Q3
$6K Buy
318
+30
+10% +$637 ﹤0.01% 2225
2022
Q2
$6K Sell
288
-43
-13% -$961 ﹤0.01% 2200
2022
Q1
$9K Buy
331
+27
+9% +$700 ﹤0.01% 2077
2021
Q4
$8K Sell
304
-78
-20% -$2.16K ﹤0.01% 2219
2021
Q3
$10K Buy
382
+275
+257% +$7.92K ﹤0.01% 2067
2021
Q2
$3K Sell
107
-77
-42% -$2.45K ﹤0.01% 2480
2021
Q1
$6K Buy
184
+46
+33% +$1.6K ﹤0.01% 2138
2020
Q4
$4K Sell
138
-1
-0.7% -$31 ﹤0.01% 2125
2020
Q3
$4K Buy
139
+32
+30% +$1.06K ﹤0.01% 2116
2020
Q2
$3K Hold
107
﹤0.01% 2115
2020
Q1
$3K Hold
107
﹤0.01% 2045
2019
Q4
$3K Hold
107
﹤0.01% 2130
2019
Q3
$2K Buy
107
+52
+95% +$859 ﹤0.01% 2195
2019
Q2
$1K Sell
55
-454
-89% -$8.93K ﹤0.01% 2225
2019
Q1
$12K Buy
509
+400
+367% +$9.02K ﹤0.01% 1454
2018
Q4
$2K Sell
109
-18
-14% -$480 ﹤0.01% 1903
2018
Q3
$4K Hold
127
﹤0.01% 1812
2018
Q2
$5K Hold
127
﹤0.01% 1603
2018
Q1
$5K Hold
127
﹤0.01% 1570
2017
Q4
$6K Hold
127
﹤0.01% 1499
2017
Q3
$5K Hold
127
﹤0.01% 1597
2017
Q2
$6K Buy
127
+18
+17% +$558 ﹤0.01% 1526
2017
Q1
$3K Buy
+109
New +$2.31K ﹤0.01% 1693

Other funds holding PETS

Parallel Advisors's PETS Position: Q3 2024 in Review

Parallel Advisors sold out of PetMed Express (PETS) in Q3 2024, closing a stake of 34 shares — an estimated $138 sold.

Parallel Advisors first reported a position in PETS in Q1 2017 and held it in 30 quarters. The position peaked at $23.7K in Q2 2023. 93 funds tracked by Wall St. Rank hold PETS as of Q3 2024.

  • Parallel Advisors reported no remaining PetMed Express position as of Q3 2024 after selling out during the quarter.
  • Parallel Advisors sold 34 PetMed Express shares in Q3 2024, an estimated $138.
  • Parallel Advisors first reported a position in PetMed Express in Q1 2017 and held it in 30 quarters.
  • Parallel Advisors's PetMed Express position peaked at $23.7K in Q2 2023.
  • 93 funds tracked by Wall St. Rank held PetMed Express as of Q3 2024.

Based on Parallel Advisors's 13F filing for Q3 2024, filed 13 Nov 2024.